While realized investment in the period was positive with a net gain of $38.3 million in the year ending June 30, MedStar reported unrealized losses on investment totaling $330.3 million compared with a gain in 2021 of $453.8 million. Overall, the group’s net loss totaled $199.3 million.
“The ability of the system to generate investment income and realized gains is dependent in large measure on market conditions,” MedStar said in its financial statements. “The market value of its investment portfolio, as well as its investment income, has been volatile in the past, and this volatility may continue in the future.”
MedStar Health operates ten hospitals in Washington D.C., and Maryland, including the Georgetown University facility in the nation’s capital, which was recently ranked among the top of its peers.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
